Category

Day: July 4, 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Read More

Bricklayer on bail over alleged window damage, theft

The Amasaman Circuit Court has granted GHC50,000.00 bail with two sureties to a bricklayer who allegedly damaged his neighbour’s window and stole her money and cell phone.

David Adjei Nortey, 25, denied causing unlawful damage to the window and the c…

Read More